📢2024 @Wilson Disease Association (WDA) Annual Conference in Charlotte, North Carolina from 4-6 October.
🤝Connect with @Sonia Valero, Head of Clinical Ops & Patient Advocacy Representative at @Vivet Therapeutics and US Patient Advocacy Consultant @Lori Mckenna, at the upcoming 📢2024 @Wilson Disease Association (WDA) Annual Conference in Charlotte, North Carolina from 4-6 October. At #Vivet, we are proud sponsors of the WDA Conference and believe patient engagement is crucial […]
Join our CEO, @Jean-Philippe Combal in the Big🍎Apple for @Chardan’s 8th Annual Genetic Medicines Conference!
Join our CEO, @Jean-Philippe Combal in the Big🍎Apple for @Chardan’s 8th Annual Genetic Medicines Conference! The premier event will bring together groundbreaking thought leaders to discuss major themes in genetic medicines through fireside chats, individual company presentations, one-on-one meetings, and panel discussions. Get in touch if you would like to connect with Jean-Philippe to learn […]
Leukodystrophy Awareness Month
📢 Leukodystrophy Awareness Month takes place throughout the whole month of September and is a time to raise awareness about these devastating rare conditions! Together 🤝 let’s shine a light💡 and increase understanding of leukodystrophy, a group of rare genetic metabolic disorders affecting the central nervous system. Leukodystrophies are characterized by the abnormal growth of […]
Vivet Therapeutics is a proud sponsor of the 2024 @European Society of Gene and Cell Therapy (#ESGCT)
Vivet Therapeutics is a proud sponsor of the 2024 @European Society of Gene and Cell Therapy (#ESGCT) meeting in Rome, Italy, from 22-25 October 🤝! 🔬 #ESGCT promotes basic and clinical research in #genetherapy, #celltherapy and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to […]
The @European Commission has granted Orphan Drug Designation (#ODD) to our gene therapy product, VTX-806, for the treatment of cerebrotendinous xanthomatosis (#CTX), a rare #neurodegenerativedisease in patients.
European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene Therapy Product for the Treatment of Cerebrotendinous Xanthomatosis (CTX) • Pre-clinical data of VTX-806 in mice demonstrated normalization of metabolic parameters in blood and brain, and of upregulated compensatory enzymes• EUR 4.9 million funding provided by French Government to develop VTX-806 as an effective treatment […]
Dr Gloria Gonzalez-Aseguinolaza, Chief Scientific Officer of Vivet Therapeutics Receives the Rosalind Franklin Society Special Award in Science
Paris, France, July 16, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders, is delighted to announce that its Co-Founder & Chief Scientific Officer, Dr Gloria Gonzalez-Aseguinolaza, PhD, has been honored with the Rosalind Franklin Society (RFS) Special Award in Science given […]
CTX Scientific & Family Meeting on the 28 June at 13.25 CST in Itasca, Illinois!
As Co-founder and Chief Scientific Officer of #VivetTherapeutics, Dr @Gloria Gonzalez-Aseguinolaza will be presenting 📢 at the upcoming #CTX Scientific & Family Meeting
Characteristics of patients with Wilson Disease in the United States: An insurance claims database study
We are delighted to share our findings in a peer reviewed paper published in the World Journal of Hepatology, titled ‘Characteristics of patients with Wilson Disease in the United States: An insurance claims database study.’
Vivet Therapeutics presents interim data on its Phase 1/2 GATEWAY trial for the Treatment of Wilson Disease at EASL Congress 2024
Vivet Therapeutics Presents Interim Data from its Phase 1/2 GATEWAY Trial for the Treatment of Wilson Disease at EASL Congress 2024 VTX-801 increased ceruloplasmin ferroxidase activity and improved liver histology
EASL Congress 2024, the home of Hepatology, from 5-8 June in Milan, Italy
🎓Are you attending the upcoming @EASL Congress 2024, the home of Hepatology, from 5-8 June in Milan, Italy! Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team
